Loading...

Allan Flach, MD, PharmD

Address10 Koret Way
San Francisco CA 94117
Phone415-476-0678
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency
    University of California, San FranciscoM.D.1971 Medicine
    University of California, San FranciscoPharm.D.1967 Pharmacy

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Laties AM, Flach AJ, Baldycheva I, Rak I, Earley W, Pathak S. Cataractogenic potential of quetiapine versus risperidone in the long-term treatment of patients with schizophrenia or schizoaffective disorder: a randomized, open-label, ophthalmologist-masked, flexible-dose, non-inferiority trial. J Psychopharmacol. 2015 Jan; 29(1):69-79. PMID: 25315830.
      View in: PubMed
    2. Flach AJ. Amsler grids for chloroquine toxicity. Ophthalmology. 2011 Oct; 118(10):2099; author reply 2099-100. PMID: 21968178.
      View in: PubMed
    3. Kim SJ, Flach AJ, Jampol LM. Nonsteroidal anti-inflammatory drugs in ophthalmology. Surv Ophthalmol. 2010 Mar-Apr; 55(2):108-33. PMID: 20159228.
      View in: PubMed
    4. Flach AJ. Intraoperative floppy iris syndrome: pathophysiology, prevention, and treatment. Trans Am Ophthalmol Soc. 2009 Dec; 107:234-9. PMID: 20126500; PMCID: PMC2814568.
    5. Flach AJ. Proposed mandate for instructions and labeling regarding the use of eye drops. Arch Ophthalmol. 2009 Sep; 127(9):1207-9. PMID: 19752433.
      View in: PubMed
    6. Flach AJ. Debunking myths in physician-industry conflicts of interest. Am J Ophthalmol. 2009 Mar; 147(3):562-3; author reply 563-4. PMID: 19217965.
      View in: PubMed
    7. Flach AJ. The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies. Trans Am Ophthalmol Soc. 2008; 106:138-45; discussion 145-8. PMID: 19277229; PMCID: PMC2646444.
    8. Flach AJ. Improving the risk-benefit relationship and informed consent for patients treated with hydroxychloroquine. Trans Am Ophthalmol Soc. 2007; 105:191-4; discussion 195-7. PMID: 18427609; PMCID: PMC2258132.
    9. Flach AJ. Misuse and abuse of topically applied nonsteroidal anti-inflammatory drugs. Cornea. 2006 Dec; 25(10):1265-6. PMID: 17172917.
      View in: PubMed
    10. Shapiro BL, Petrovic V, Lee SE, Flach A, McCaffery S, O'Brien JM. Choroidal detachment following the use of tamsulosin (Flomax). Am J Ophthalmol. 2007 Feb; 143(2):351-3. PMID: 17258532.
      View in: PubMed
    11. Waterbury LD, Flach AJ. Comparison of ketorolac tromethamine, diclofenac sodium, and loteprednol etabonate in an animal model of ocular inflammation. J Ocul Pharmacol Ther. 2006 Jun; 22(3):155-9. PMID: 16808675.
      View in: PubMed
    12. Waterbury LD, Flach AJ. Efficacy of low concentrations of ketorolac tromethamine in animal models of ocular inflammation. J Ocul Pharmacol Ther. 2004 Aug; 20(4):345-52. PMID: 15321029.
      View in: PubMed
    13. Flach AJ. Does medical treatment influence the success of trabeculectomy? Trans Am Ophthalmol Soc. 2004; 102:219-23; discussion 223-4. PMID: 15747760; PMCID: PMC1280102.
    14. Flach AJ. Topical nonsteroidal antiinflammatory drugs in ophthalmology. Int Ophthalmol Clin. 2002; 42(1):1-11. PMID: 12189605.
      View in: PubMed
    15. Flach AJ. Delta-9-tetrahydrocannabinol (THC) in the treatment of end-stage open-angle glaucoma. Trans Am Ophthalmol Soc. 2002; 100:215-22; discussion 222-4. PMID: 12545695; PMCID: PMC1358964.
    16. Flach A. Additional factors linking corneal melting to topical nonsteroidal anti-inflammatory drugs. Arch Ophthalmol. 2001 Jul; 119(7):1085. PMID: 11448339.
      View in: PubMed
    17. Flach AJ. Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs. Trans Am Ophthalmol Soc. 2001; 99:205-10; discussion 210-2. PMID: 11797308; PMCID: PMC1359011.
    18. Flach A. Topically applied nonsteroidal anti-inflammatory drugs and corneal problems: an interim review and comment. Ophthalmology. 2000 Jul; 107(7):1224-6. PMID: 10889089.
      View in: PubMed
    19. Flach AJ, Dolan BJ. Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation. Trans Am Ophthalmol Soc. 2000; 98:101-5; discussion 105-7. PMID: 11190013; PMCID: PMC1298216.
    20. Flach AJ, Dolan BJ, Donahue ME, Faktorovich EG, Gonzalez GA. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery. Ophthalmology. 1998 Sep; 105(9):1775-9. PMID: 9754191.
      View in: PubMed
    21. Flach AJ. The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc. 1998; 96:557-634. PMID: 10360304; PMCID: PMC1298410.
    22. Flach A. Acetazolamide treatment of CME in patients with uveitis. Ophthalmology. 1996 Nov; 103(11):1715-6; author reply 1716-7. PMID: 8942859.
      View in: PubMed
    23. Flach AJ. Ocular pharmacology and toxicology. Ophthalmology. 1996 Aug; 103(8 Suppl):S118-42. PMID: 8764773.
      View in: PubMed
    24. Flach AJ. Topical nonsteroidal antiinflammatory drugs for ophthalmic use. Int Ophthalmol Clin. 1996; 36(2):77-83. PMID: 8950635.
      View in: PubMed
    25. Flach AJ, Smith RE, Fraunfelder FT. Stevens-Johnson syndrome associated with methazolamide treatment reported in two Japanese-American women. Ophthalmology. 1995 Nov; 102(11):1677-80. PMID: 9098261.
      View in: PubMed
    26. Flach AJ. Efficacy of apraclonidine ophthalmic solution (iopidine) in presumed silicon oil-induced glaucoma and primary open-angle glaucoma. Surv Ophthalmol. 1995 Jul-Aug; 40(1):84-5. PMID: 8545811.
      View in: PubMed
    27. Flach AJ, Donahue ME. Pet flea and tick collar-induced anisocoria. Arch Ophthalmol. 1994 May; 112(5):586. PMID: 8185512.
      View in: PubMed
    28. Flach AJ. Systemic toxicity. Associated with topical ophthalmic medications. J Fla Med Assoc. 1994 Apr; 81(4):256-60. PMID: 8046365.
      View in: PubMed
    29. Flach AJ. Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity: a prospective study of 63 patients. Surv Ophthalmol. 1994 Jan-Feb; 38(4):392-3. PMID: 8160114.
      View in: PubMed
    30. Flach AJ, Dolan BJ. Progression of amiodarone induced cataracts. Doc Ophthalmol. 1993; 83(4):323-9. PMID: 8223102.
      View in: PubMed
    31. Flach AJ. Nonsteroidal anti-inflammatory drugs in ophthalmology. Int Ophthalmol Clin. 1993; 33(4):1-7. PMID: 8258490.
      View in: PubMed
    32. Flach A, Donahue ME, Wood IS. Nerve terminal degeneration in the rat iris observed following chronic topical 2% epinephrine and 0.1% dipivalyl epinephrine: a quantitative comparison of electron microscopic observations and tissue norepinephrine levels. Graefes Arch Clin Exp Ophthalmol. 1992; 230(6):575-9. PMID: 1427143.
      View in: PubMed
    33. Flach A. Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol. 1992 Jan-Feb; 36(4):259-84. PMID: 1549810.
      View in: PubMed
    34. Flach A, Donahue ME. Effects of topically applied 2% epinephrine and 0.1% dipivalyl epinephrine on the adrenergic nerves as revealed by histofluorescence. Ophthalmologica. 1992; 205(2):96-9. PMID: 1475087.
      View in: PubMed
    35. Flach AJ, Jampol LM, Weinberg D, Kraff MC, Yannuzzi LA, Campo RV, Neumann AC, Cupples HP, Lefler WH, Pulido JS. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol. 1991 Nov 15; 112(5):514-9. PMID: 1951587.
      View in: PubMed
    36. Flach A. Glaucoma treatment and pregnancy. Arch Ophthalmol. 1991 Apr; 109(4):463. PMID: 2012532.
      View in: PubMed
    37. Flach A, Dolan BJ. Amiodarone-induced lens opacities: an 8-year follow-up study. Arch Ophthalmol. 1990 Dec; 108(12):1668-9. PMID: 2256828.
      View in: PubMed
    38. Flach A, Stegman RC, Graham J, Kruger LP. Prophylaxis of aphakic cystoid macular edema without corticosteroids. A paired-comparison, placebo-controlled double-masked study. Ophthalmology. 1990 Oct; 97(10):1253-8. PMID: 2243674.
      View in: PubMed
    39. Flach A, Lavoie PE. Episcleritis, conjunctivitis, and keratitis as ocular manifestations of Lyme disease. Ophthalmology. 1990 Aug; 97(8):973-5. PMID: 2205817.
      View in: PubMed
    40. Flach A, Jaffe NS, Akers WA. The effect of ketorolac tromethamine in reducing postoperative inflammation: double-mask parallel comparison with dexamethasone. Ann Ophthalmol. 1989 Nov; 21(11):407-11. PMID: 2619149.
      View in: PubMed
    41. Flach A. Cystoid macular edema following cataract surgery. Arch Ophthalmol. 1989 Feb; 107(2):166-7. PMID: 2916962.
      View in: PubMed
    42. Flach A, Lavelle CJ, Olander KW, Retzlaff JA, Sorenson LW. The effect of ketorolac tromethamine solution 0.5% in reducing postoperative inflammation after cataract extraction and intraocular lens implantation. Ophthalmology. 1988 Sep; 95(9):1279-84. PMID: 3062540.
      View in: PubMed
    43. Flach AJ, Kraff MC, Sanders DR, Tanenbaum L. The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier. Arch Ophthalmol. 1988 Apr; 106(4):480-3. PMID: 3355415.
      View in: PubMed
    44. Flach AJ, Graham J, Kruger LP, Stegman RC, Tanenbaum L. Quantitative assessment of postsurgical breakdown of the blood-aqueous barrier following administration of 0.5% ketorolac tromethamine solution. A double-masked, paired comparison with vehicle-placebo solution study. Arch Ophthalmol. 1988 Mar; 106(3):344-7. PMID: 3345153.
      View in: PubMed
    45. Flach A, Eliason JA. Topical prostaglandin E2 effects on normal human intraocular pressure. J Ocul Pharmacol. 1988; 4(1):13-8. PMID: 3171331.
      View in: PubMed
    46. Flach AJ, Dolan BJ, Irvine AR. Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema. Am J Ophthalmol. 1987 Apr 15; 103(4):479-86. PMID: 3551617.
      View in: PubMed
    47. Flach AJ, Peterson JS, Donahue ME. Ocular hypertensive responses in pigmented rabbits following different methods of waterloading. J Ocul Pharmacol. 1986; 2(4):313-7. PMID: 3503115.
      View in: PubMed
    48. Flach AJ. Dangers of ocular instillation of medications. West J Med. 1985 Sep; 143(3):391. PMID: 4049862; PMCID: PMC1306347.
    49. Dolan BJ, Flach AJ, Peterson JS. Amiodarone keratopathy and lens opacities. J Am Optom Assoc. 1985 Jun; 56(6):468-70. PMID: 4008856.
      View in: PubMed
    50. Flach AJ, Dolan BJ. The therapy of Adie's syndrome with dilute pilocarpine hydrochloride solutions. J Ocul Pharmacol. 1985; 1(4):353-62. PMID: 3880084.
      View in: PubMed
    51. Flach AJ, Peterson JS, Dolan BJ. Anterior subcapsular cataracts: a review of potential etiologies. Ann Ophthalmol. 1985 Jan; 17(1):78-80. PMID: 3977225.
      View in: PubMed
    52. Flach AJ, Dolan BJ. Adie's syndrome: a medical treatment for symptomatic patients. Ann Ophthalmol. 1984 Dec; 16(12):1151-4. PMID: 6532290.
      View in: PubMed
    53. Flach AJ, Dolan B, Sudduth B. The use of amiodarone in children. Pacing Clin Electrophysiol. 1984 Nov; 7(6 Pt 1):1086-7. PMID: 6209628.
      View in: PubMed
    54. Flach AJ, Peterson JS, Seligmann KA. Local ocular hypotensive effect of topically applied acetazolamide. Am J Ophthalmol. 1984 Jul 15; 98(1):66-72. PMID: 6742080.
      View in: PubMed
    55. Flach AJ. Ophthalmology-Important Advances in Clinical Medicine: Severe Systemic Effects From Topically Applied beta-Adrenergic Blocking Agents. West J Med. 1984 Feb; 140(2):269. PMID: 18749497.
      View in: PubMed
    56. Flach AJ, Roizen MF, Wood IS, Peterson JS. Post-ganglionic chemical sympathectomy of the cat nictitating membrane following systemic epinephrine: degeneration of nerve terminals followed by regeneration. Exp Eye Res. 1983 Nov; 37(5):447-53. PMID: 6671473.
      View in: PubMed
    57. Flach AJ, Dolan BJ, Sudduth B, Weddell J. Amiodarone-induced lens opacities. Arch Ophthalmol. 1983 Oct; 101(10):1554-6. PMID: 6626008.
      View in: PubMed
    58. Flach AJ. A registry of potential product substitutions of particular danger for ophthalmology. Am J Ophthalmol. 1983 Sep; 96(3):404-5. PMID: 6614121.
      View in: PubMed
    59. Flach AJ, Sorenson JA. Eyewash mistaken for contact lens soaking solution. Am J Ophthalmol. 1983 Jun; 95(6):850-1. PMID: 6859204.
      View in: PubMed
    60. Flach AJ, Peterson JS, Roizen MF, Wood IS. Ptosis in the rat following topically administered 2% epinephrine. Invest Ophthalmol Vis Sci. 1983 Jun; 24(6):766-71. PMID: 6406386.
      View in: PubMed
    61. Flach AJ, Stone DR, Becker CE, Peterson JS. Chromatopsia related to afterimages. Am J Ophthalmol. 1982 Dec; 94(6):811-2. PMID: 6983833.
      View in: PubMed
    62. Flach A, Murphy A. Cortisporin dispensing error. Am J Ophthalmol. 1982 Oct; 94(4):565-7. PMID: 6291395.
      View in: PubMed
    63. Flach AJ. Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol. Am J Ophthalmol. 1982 Sep; 94(3):420-2. PMID: 7124889.
      View in: PubMed
    64. Flach AJ, Peterson JS, Mathias CG. Photosensitivity to topically applied sulfisoxazole ointment: evidence for a phototoxic reaction. Arch Ophthalmol. 1982 Aug; 100(8):1286-7. PMID: 7103813.
      View in: PubMed
    65. Flach AJ. Chloramphenicol and aplastic anemia. Am J Ophthalmol. 1982 May; 93(5):664-6. PMID: 7081370.
      View in: PubMed
    66. Flach AJ, Peterson JS, Wood I, Roizen MF. Degeneration of nerve terminals in cats following systemic epinephrine: depletion of tissue norepinephrine correlated with ultrastructural changes. Exp Eye Res. 1981 Apr; 32(4):389-94. PMID: 7238624.
      View in: PubMed
    67. Flach A. Photosensitivity to sulfisoxazole ointment. Arch Ophthalmol. 1981 Apr; 99(4):609-10. PMID: 7224931.
      View in: PubMed
    68. Flach AJ, Kramer SG. Supersensitivity to topical epinephrine after long-term epinephrine therapy. Arch Ophthalmol. 1980 Mar; 98(3):482-3. PMID: 7362503.
      View in: PubMed
    69. Flach A. The fluorescein appearance test for lacrimal obstruction. Ann Ophthalmol. 1979 Feb; 11(2):237-42. PMID: 434742.
      View in: PubMed
    70. Flach A, Wood I. An electron microscopic study of degeneration of nerve terminals after administration of epinephrine. Exp Eye Res. 1978 Oct; 27(4):377-85. PMID: 729652.
      View in: PubMed
    71. Flach A. Symblepharon in sarcoidosis. Am J Ophthalmol. 1978 Feb; 85(2):210-4. PMID: 623192.
      View in: PubMed
    72. Flach A. Fluorescein oropharyngoscopy. Am J Ophthalmol. 1976 Dec; 82(6):940-2. PMID: 998711.
      View in: PubMed
    73. Flach A. The pilocarpine Ocusert Delivery System. Trans Pac Coast Otoophthalmol Soc Annu Meet. 1974; 55:179-208. PMID: 4480721.
      View in: PubMed
    74. Flach A. [Intra vitam microscopic observations on capillaries and arterioles of the periphery of the lung following various stimuli]. Bibl Anat. 1965; 7:101-5. PMID: 5860716.
      View in: PubMed
    Allan's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP